Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
- 1 June 1995
- journal article
- Published by Elsevier in Clinical Radiology
- Vol. 50 (6) , 384-390
- https://doi.org/10.1016/s0009-9260(05)83135-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.Radiology, 1992
- Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.Radiology, 1992
- Assessment of Osteosarcoma Response to Preoperative Chemotherapy Using Dynamic FLASH Gadolinium-DTPA-Enhanced Magnetic Resonance MappingInvestigative Radiology, 1992
- Osteosarcoma: chemotherapy-induced changes at MR imaging.Radiology, 1992
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992
- Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.Journal of Clinical Oncology, 1992
- Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.American Journal of Roentgenology, 1991
- Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.Radiology, 1990
- The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.American Journal of Roentgenology, 1990
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984